These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37944131)

  • 1. Identification of Brugada syndrome based on P-wave features: an artificial intelligence-based approach.
    Zanchi B; Faraci FD; Gharaviri A; Bergonti M; Monga T; Auricchio A; Conte G
    Europace; 2023 Nov; 25(11):. PubMed ID: 37944131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concealed abnormal atrial phenotype in patients with Brugada syndrome and no history of atrial fibrillation.
    Conte G; Caputo ML; Volders PGA; Luca A; Mainardi L; Schotten U; Corino VDA; Regoli F; Zeemering S; Zink M; Yazdani S; Kappenberger L; Moccetti T; Vesin JM; Auricchio A
    Int J Cardiol; 2018 Feb; 253():66-70. PubMed ID: 29306474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel CineECG Derived From Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients With Brugada Syndrome.
    van Dam PM; Locati ET; Ciconte G; Borrelli V; Heilbron F; Santinelli V; Vicedomini G; Monasky MM; Micaglio E; Giannelli L; Mecarocci V; Ćalović Ž; Anastasia L; Pappone C
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008524. PubMed ID: 32755392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate variability and microvolt T wave alternans changes during ajmaline test may predict prognosis in Brugada syndrome.
    Călburean PA; Pannone L; Sorgente A; Gauthey A; Monaco C; Strazdas A; Almorad A; Bisignani A; Bala G; Ramak R; Overeinder I; Ströker E; Pappaert G; Van Dooren S; de Ravel T; La Meir M; Brugada P; Sieira J; Chierchia GB; de Asmundis C
    Clin Auton Res; 2023 Feb; 33(1):51-62. PubMed ID: 36645559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
    Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
    Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic evidence of abnormal atrial phenotype in Brugada syndrome.
    Tse G; Reddy S; Chopra J; Lee S; Liu T; Bazoukis G; Haseeb S; Lee APW; Letsas KP; Li KHC
    J Electrocardiol; 2019; 55():102-106. PubMed ID: 31152990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ajmaline Testing and the Brugada Syndrome.
    Rizzo A; Borio G; Sieira J; Van Dooren S; Overeinder I; Bala G; Pappaert G; Maj R; Osório TG; Terasawa M; Galli A; Cecchini F; Miraglia V; Ströker E; La Meir M; Brugada P; Chierchia GB; de Asmundis C
    Am J Cardiol; 2020 Nov; 135():91-98. PubMed ID: 32861732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial Abnormalities in Brugada Syndrome: Evaluation With ECG Imaging.
    Bisignani A; Pannone L; Del Monte A; Eltsov I; Cappello IA; Sieira J; Monaco C; Bala G; Mouram S; Della Rocca DG; Ströker E; Overeinder I; Almorad A; Pappaert G; Gauthey A; de Ravel T; Van Dooren S; Sorgente A; La Meir M; Sarkozy A; Brugada P; Chierchia GB; de Asmundis C
    JACC Clin Electrophysiol; 2023 Oct; 9(10):2096-2105. PubMed ID: 37565952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients.
    Thapanasuta M; Chokesuwattanaskul R; Leelapatana P; Rungpradubvong V; Prechawat S
    Med Sci (Basel); 2022 Dec; 10(4):. PubMed ID: 36548004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.
    Conte G; Kawabata M; de Asmundis C; Taravelli E; Petracca F; Ruggiero D; Caputo ML; Regoli F; Chierchia GB; Chiodini A; Del Bufalo A; Moccetti T; Goya M; Hirao K; Vicentini A; De Ferrari GM; Brugada P; Auricchio A
    Europace; 2018 Jul; 20(7):1188-1193. PubMed ID: 28340026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic characteristics of premature ventricular contractions in subjects with type 1 pattern of Brugada syndrome.
    Letsas KP; Asvestas D; Vlachos K; Karlis D; Korantzopoulos P; Efremidis M; Sideris A
    J Electrocardiol; 2014; 47(3):351-5. PubMed ID: 24636795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.
    Postema PG; van Dessel PF; Kors JA; Linnenbank AC; van Herpen G; Ritsema van Eck HJ; van Geloven N; de Bakker JM; Wilde AA; Tan HL
    J Am Coll Cardiol; 2010 Feb; 55(8):789-97. PubMed ID: 20170818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the Presence of Ventricular Fibrillation From a Brugada Electrocardiogram Using Artificial Intelligence.
    Nakamura T; Aiba T; Shimizu W; Furukawa T; Sasano T
    Circ J; 2023 Jun; 87(7):1007-1014. PubMed ID: 36372400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.